Patient with cardioembolic stroke: clinical characteristics and typical features

Aim. To evaluate basic clinicopathologicalcharacteristics of patients with atrial fibrillationand pharmacological anamnesis at the time of cardioembolicstroke.

Material and Methods. Study included 99 patientswith atrial fibrillation admitted to SeredavinSamara Regional Clinical Hospital due to cardioembolicstroke. The follow-up duration was 1year.

Results. The average age of the patients was69.1 ± 8.7 years. Patients with atrial fibrillationand acute cardioembolic stroke were characterizedby multimorbidity. Arterial hypertension, chronickidney disease, and diabetes mellitus were diagnosedin 96/99 (97.0%), 60/99 (60.6%), and 22/99(22.2%) patients, respectively. Average risk scoreaccording to the CHA2DS2-VASc scale before admissionwas 4.51 ± 1.2 points; therefore, 96 patientshad indications for anticoagulant therapy (≥2 points on the CHA2DS2-VASc scale). However,adequate prevention of thromboembolic complicationsbefore admission was carried out only in16/99 (16.2%) patients.

Conclusion. These results demonstrate a lowquality of outpatient care in patients with atrialfibrillation. Most likely, this can be explained bythe lack of awareness about the risks of potentialcomplications and low compliance.

1. Yaghi S, Bernstein RA, Passman R, Okin PM, Furie KL.Cryptogenic Stroke: Research and Practice. Circ Res.2017;120(3):527-540. https://doi.org/10.1161/CIRCRESAHA.116.308447

2. Thrift AG, Thayabaranathan T, Howard G, Howard VJ, RothwellPM, Feigin VL, Norrving B, Donnan GA, Cadilhac DA.Global stroke statistics. Int J Stroke. 2017;12(1):13-32. https://doi.org/10.1177/1747493016676285

3. Yushan B, Tan BYQ, Ngiam NJ, Chan BPL, Luen TH,Sharma VK, Sia CH, Dalakoti M, Chong SS, KojodjojoP, Yeo LLL. Association between Bilateral Infarcts Patternand Detection of Occult Atrial Fibrillation in EmbolicStroke of Undetermined Source (ESUS) Patients with InsertableCardiac Monitor (ICM). J Stroke Cerebrovasc Dis.2019;28(9):2448-2452. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.06.025

4. Verma N, Ziegler PD, Liu S, Passman RS. Incidence ofatrial fibrillation among patients with an embolic strokeof undetermined source: Insights from insertable cardiacmonitors. Int J Stroke. 2019;14(2):146-153. https://doi.org/10.1177/1747493018798554

5. Boytsov SA, Luk'yanov MM, YakushinSS, Martsevich SYu, Vorobyov AN, Zagrebelny AV, PereverzevaKG, Pravkina EA, Deev AD, Andreenko EYu, ErshovaAI, Meshkov AN, Myasnikov RP, Serdyuk SS, Kharlap MS,Bazaeva EV, Kozminsky AN, Moseychuk KA, KudryashovEN. Cardiovascular diseases registry (RECVAZA): diagnostics,concomitant cardiovascular pathology, comorbidities andtreatment in the real outpatient-polyclinic practice. Cardiovasculartherapy and prevention. 2014;13(6):44-50. (In Russ.). https://doi.org/10.15829/1728-8800-2014-6-44-50

6. Albert NM. Use of novel oral anticoagulants for patients withatrial fibrillation: systematic review and clinical implications.Heart Lung. 2014;43(1):48-59. https://doi.org/10.1016/j.hrtlng.2013.10.014

7. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, CasadeiB, Castella M, Diener HC, Heidbuchel H, Hendriks J, HindricksG, Manolis AS, Oldgren J, Popescu BA, Schotten U, VanPutte B, Vardas P; ESC Scientific Document Group. 2016 ESCguidelines for the management of atrial fbrillation developedin collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. https://doi.org/10.1093/eurheartj/ehw210

8. Shmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillationin acute myocardial infarction: a systematic review of theincidence, clinical features and prognostic implications. EurHeart J. 2009;30(9):1038-1045. https://doi.org/10.1093/eurheartj/ehn579

9. Tadic M, Cuspidi C. Type 2 diabetes mellitus and atrialfibrillation: From mechanisms to clinical practice. Arch CardiovascDis. 2015;108(4):269-276. https://doi.org/10.1016/j.acvd.2015.01.009

10. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández AI,Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causesof Death in Anticoagulated Patients With Atrial Fibrillation.J Am Coll Cardiol. 2016;68(23):2508-2521. https://doi.org/10.1016/j.jacc.2016.09.944

11. Lau YC, Proietti M, Guiducci E, Blann AD, Lip GYH. AtrialFibrillation and Thromboembolism in Patients With ChronicKidney Disease. J Am Coll Cardiol. 2016;68(13):1452-1464.https://doi.org/10.1016/j.jacc.2016.06.057

12. Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillationand arterial hypertension. Pharmacol Res. 2018;128:322-326.https://doi.org/10.1016/j.phrs.2017.10.007

13. Hidirova LD, Yakhontov DA, ZeninSA. Atrial fibrillation in comorbid patients depending on thetreatment regimen. Kompleksnye problemy serdechno-sosudistykhzabolevaniy. 2019;8(2):21-29. (In Russ.).https://doi.org/10.17802/2306-1278-2019-8-2-21-29